The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Drug induced liver injury: an update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress
Nguyen, T., Nioi, P., & Pickett, C. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900010200 · Cited by 2,655
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Immune checkpoint inhibitors: recent progress and potential biomarkers
Darvin, P., Toor, S. M., Sasidharan Nair, V., & Elkord, E. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0191-1 · Cited by 2,035
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025
Bastuji‐Garin, S. (1993) · Archives of Dermatology · doi:10.1001/archderm.129.1.92 · Cited by 1,697
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature
Casagranda, A., Suppa, M., Dehavay, F., & del Marmol, V. (2017) · Case Reports in Dermatology · doi:10.1159/000475802 · Cited by 1,466
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Self-citationBernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106 · cited 3×
“Classically, a positive rechallenge has been defined as doubling of ALT or ALP in hepatocellular or cholestatic/mixed type of liver injury, respectively (Benichou 1990).”
BackgroundCase definition and phenotype standardization in drug-induced liver injury
Aithal, G. P., Watkins, P. B., Andrade, R. J., Larrey, D., Molokhia, M., Takikawa, H., Hunt, C. M., Wilke, R. A., Avigan, M., Kaplowitz, N., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.58 · Cited by 944
Self-citationHLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
study, F. T. D., Daly, A. K., International SAE Consortium, Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe'er, I., Floratos, A., Daly, M. J., Goldstein, D. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.379 · Cited by 944
Kardaun, S. H., Sidoroff, A., Valeyrie-Allanore, L., Halevy, S., Davidovici, B. B., Mockenhaupt, M., & Roujeau, J. C. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07704.x · Cited by 934
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationKubes, P., & Jenne, C. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052415 · Cited by 923
Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
ANDRADE, R., LUCENA, M., FERNANDEZ, M., PELAEZ, G., PACHKORIA, K., GARCIARUIZ, E., GARCIAMUNOZ, B., GONZALEZGRANDE, R., PIZARRO, A., & DURAN, J. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.006 · Cited by 856
Self-citationDrug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Chalasani, N., Fontana, R. J., Bonkovsky, H. L., Watkins, P. B., Davern, T., Serrano, J., Yang, H., & Rochon, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.011 · Cited by 755
RUCAM in Drug and Herb Induced Liver Injury: The Update
Danan, G., & Teschke, R. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010014 · Cited by 729
Incidence of drug-induced hepatic injuries: A French population-based study
Sgro, C., Clinard, F., Ouazir, K., Chanay, H., Allard, C., Guilleminet, C., Lenoir, C., Lemoine, A., & Hillon, P. (2002) · Hepatology · doi:10.1053/jhep.2002.34857 · Cited by 716
Stepan, A. F., Walker, D. P., Bauman, J., Price, D. A., Baillie, T. A., Kalgutkar, A. S., & Aleo, M. D. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200168d · Cited by 698
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Gut microbiome interactions with drug metabolism, efficacy, and toxicity
Wilson, I. D., & Nicholson, J. K. (2017) · Translational Research · doi:10.1016/j.trsl.2016.08.002 · Cited by 656
Drug-induced liver injury—types and phenotypes
Hoofnagle, J. H., & Björnsson, E. S. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1816149 · Cited by 652
Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver
Maddrey, W. C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70192-2 · Cited by 646
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
Shen, T., Liu, Y., Shang, J., Xie, Q., Li, J., Yan, M., Xu, J., Niu, J., Liu, J., Watkins, P. B., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.002 · Cited by 615
Self-citationLee, W. M., Hynan, L. S., Rossaro, L., Fontana, R. J., Stravitz, R. T., Larson, A. M., Davern, T. J., Murray, N. G., McCashland, T., Reisch, J. S., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.006 · Cited by 607
Epidemiology of hepatocellular adenoma. The role of oral contraceptive use
Rooks, J. B. (1979) · JAMA · doi:10.1001/jama.242.7.644 · Cited by 588
Outcome and prognostic markers in severe drug‐induced liver disease†
Björnsson, E., & Olsson, R. (2005) · Hepatology · doi:10.1002/hep.20800 · Cited by 524
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
De Martin, E., Michot, J.-M., Papouin, B., Champiat, S., Mateus, C., Lambotte, O., Roche, B., Antonini, T. M., Coilly, A., Laghouati, S., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.033 · Cited by 520
Benichou, C., Danan, G., & Flahault, A. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90102-7 · Cited by 491
Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct
Fontana, R. J., Watkins, P. B., Bonkovsky, H. L., Chalasani, N., Davern, T., Serrano, J., & Rochon, J. (2009) · Drug Safety · doi:10.2165/00002018-200932010-00005 · Cited by 486
Lucena, M. I., Molokhia, M., Shen, Y., Urban, T. J., Aithal, G. P., Andrade, R. J., Day, C. P., Ruiz–Cabello, F., Donaldson, P. T., Stephens, C., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.001 · Cited by 442
Self-citationDrug-induced liver injury: recent advances in diagnosis and risk assessment
Kullak-Ublick, G. A., Andrade, R. J., Merz, M., End, P., Benesic, A., Gerbes, A. L., & Aithal, G. P. (2017) · Gut · doi:10.1136/gutjnl-2016-313369 · Cited by 438
Self-citationDrug-induced autoimmune hepatitis: clinical characteristics and prognosis
Björnsson, E., Talwalkar, J., Treeprasertsuk, S., Kamath, P. S., Takahashi, N., Sanderson, S., Neuhauser, M., & Lindor, K. (2010) · Hepatology · doi:10.1002/hep.23588 · Cited by 436
MacSween's Pathology of the Liver
(2012) · Elsevier eBooks · doi:10.1016/c2009-0-47964-9 · Cited by 420
Acute and clinically relevant drug‐induced liver injury: a population based case‐control study
De Abajo, F. J., Montero, D., Madurga, M., & Rodríguez, L. A. G. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02133.x · Cited by 408
Drug-induced liver injury: Interactions between drug properties and host factors
Chen, M., Suzuki, A., Borlak, J., Andrade, R. J., & Lucena, M. I. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.016 · Cited by 405
Self-citationKleiner, D. E., Chalasani, N. P., Lee, W. M., Fontana, R. J., Bonkovsky, H. L., Watkins, P. B., Hayashi, P. H., Davern, T. J., Navarro, V., Reddy, R., et al. (2014) · Hepatology · doi:10.1002/hep.26709 · Cited by 396
Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis
Maria, V. A., & Victorino, R. M. (1997) · Hepatology · doi:10.1002/hep.510260319 · Cited by 351
Chen, M., Borlak, J., & Tong, W. (2013) · Hepatology · doi:10.1002/hep.26208 · Cited by 348
Fontana, R. J., Seeff, L. B., Andrade, R. J., Björnsson, E., Day, C. P., Serrano, J., & Hoofnagle, J. H. (2010) · Hepatology · doi:10.1002/hep.23696 · Cited by 324
Self-citationHepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
Björnsson, E., Jacobsen, E. I., & Kalaitzakis, E. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.023 · Cited by 321
Histological patterns in drug-induced liver disease
Ramachandran, R., & Kakar, S. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.058248 · Cited by 319
Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
Fontana, R. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.032 · Cited by 313
Rockey, D. C., Seeff, L. B., Rochon, J., Freston, J., Chalasani, N., Bonacini, M., Fontana, R. J., & Hayashi, P. H. (2010) · Hepatology · doi:10.1002/hep.23577 · Cited by 313
Andrade, R. J., Lucena, I. M., Kaplowitz, N., García-Muņoz, B., Borraz, Y., Pachkoria, K., García-Cortés, M., Fernández, C. M., Pelaez, G., Rodrigo, L., et al. (2006) · Hepatology · doi:10.1002/hep.21424 · Cited by 309
Self-citationRobles–Diaz, M., Lucena, M. I., Kaplowitz, N., Stephens, C., Medina–Cáliz, I., González–Jimenez, A., Ulzurrun, E., Gonzalez, A. F., Fernandez, M. C., Romero–Gómez, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.050 · Cited by 301
Self-citationFunk, C., Ponelle, C., Scheuermann, G., & Pantze, M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12255-9 · Cited by 296
The future of drug safety testing: expanding the view and narrowing the focus
Stevens, J. L., & Baker, T. K. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.11.009 · Cited by 286
Central role of mitochondria in drug-induced liver injury
Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.604086 · Cited by 277
Carnitine in the treatment of valproic acid-induced toxicity
Lheureux, P. E. R., & Hantson, P. (2009) · Clinical Toxicology · doi:10.1080/15563650902752376 · Cited by 274
Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis
Iorga, A., Dara, L., & Kaplowitz, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051018 · Cited by 268
Carnitine deficiency and hyperammonemia associated with valproic acid therapy
Ohtani, Y., Endo, F., & Matsuda, I. (1982) · The Journal of Pediatrics · doi:10.1016/s0022-3476(82)80320-x · Cited by 263
Monshi, M. M., Faulkner, L., Gibson, A., Jenkins, R. E., Farrell, J., Earnshaw, C. J., Alfirevic, A., Cederbrant, K., Daly, A. K., French, N., et al. (2013) · Hepatology · doi:10.1002/hep.26077 · Cited by 258
Björnsson, E. S., & Hoofnagle, J. H. (2016) · Hepatology · doi:10.1002/hep.28323 · Cited by 245
Androgens and liver tumors: Fanconi's anemia and non‐Fanconi's conditions
Velazquez, I., & Alter, B. P. (2004) · American Journal of Hematology · doi:10.1002/ajh.20183 · Cited by 237
Church, R. J., Kullak‐Ublick, G. A., Aubrecht, J., Bonkovsky, H. L., Chalasani, N., Fontana, R. J., Goepfert, J. C., Hackman, F., King, N. M. P., Kirby, S., et al. (2019) · Hepatology · doi:10.1002/hep.29802 · Cited by 231
Self-citationSpectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network
Russo, M. W., Hoofnagle, J. H., Gu, J., Fontana, R. J., Barnhart, H., Kleiner, D. E., Chalasani, N., & Bonkovsky, H. L. (2014) · Hepatology · doi:10.1002/hep.27157 · Cited by 222
A prospective nationwide study of drug-induced liver injury in Korea
Suk, K. T., Kim, D. J., Kim, C. H., Park, S. H., Yoon, J. H., Kim, Y. S., Baik, G. H., Kim, J. B., Kweon, Y. O., Kim, B. I., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.138 · Cited by 221
Nicoletti, P., Aithal, G. P., Bjornsson, E. S., Andrade, R. J., Sawle, A., Arrese, M., Barnhart, H. X., Bondon-Guitton, E., Hayashi, P. H., Bessone, F., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.016 · Cited by 221
Self-citationComparison of Two Clinical Scales for Causality Assessment in Hepatotoxicity
Lucena, M. I., Camargo, R., Andrade, R. J., Perez-Sanchez, C. J., & De La Cuesta, F. S. (2001) · Hepatology · doi:10.1053/jhep.2001.20645 · Cited by 212
Self-citationFisher, K., Vuppalanchi, R., & Saxena, R. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0214-ra · Cited by 208
The natural history of histologically proved drug induced liver disease
Aithal, P. G., & Day, C. P. (1999) · Gut · doi:10.1136/gut.44.5.731 · Cited by 202
Steroid Use in Acute Liver Failure
Karkhanis, J., Verna, E. C., Chang, M. S., Stravitz, T. R., Schilsky, M., Lee, W. M., & Brown, R. S. (2014) · Hepatology · doi:10.1002/hep.26678 · Cited by 199
Han, D., Dara, L., Win, S., Than, T. A., Yuan, L., Abbasi, S. Q., Liu, Z.-X., & Kaplowitz, N. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.009 · Cited by 196
Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists
Andrade, R. J., Robles, M., Fernández-Castañer, A., López-Ortega, S., López-Vega, M.-C., & Lucena, M.-I. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i3.329 · Cited by 188
Self-citationYantorno, S. E., Kremers, W. K., Ruf, A. E., Trentadue, J. J., Podestá, L. G., & Villamil, F. G. (2007) · Liver Transplantation · doi:10.1002/lt.21104 · Cited by 187
Acute liver failure in Sweden: etiology and outcome
Wei, G., Bergquist, A., Broomé, U., Lindgren, S., Wallerstedt, S., Almer, S., Sangfelt, P., Danielsson, Å., Sandberg‐Gertzén, H., Lööf, L., et al. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01818.x · Cited by 185
Animal models of drug-induced liver injury
McGill, M. R., & Jaeschke, H. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.037 · Cited by 185
Effect of l -carnitine treatment for valproate-induced hepatotoxicity
Bohan, T. P., Helton, E., McDonald, I., König, S., Gazitt, S., Sugimoto, T., Scheffner, D., Cusmano, L., Li, S., & Koch, G. (2001) · Neurology · doi:10.1212/wnl.56.10.1405 · Cited by 184
Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic
DE VALLE, M. B., AV KLINTEBERG, V., ALEM, N., OLSSON, R., & BJÖRNSSON, E. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03117.x · Cited by 179
Liver–Microbiome Axis in Health and Disease
Adolph, T. E., Grander, C., Moschen, A. R., & Tilg, H. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.05.002 · Cited by 178
Nodular regenerative hyperplasia: Evolving concepts on underdiagnosed cause of portal hypertension
Hartleb, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i11.1400 · Cited by 177
Lheureux (2005) · doi:10.1186/cc3742 · Cited by 176
Causality assessment methods in drug induced liver injury: Strengths and weaknesses
García-Cortés, M., Stephens, C., Lucena, M. I., Fernández-Castañer, A., & Andrade, R. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.007 · Cited by 169
Self-citationRochon, J., Protiva, P., Seeff, L. B., Fontana, R. J., Liangpunsakul, S., Watkins, P. B., Davern, T., & McHutchison, J. G. (2008) · Hepatology · doi:10.1002/hep.22442 · Cited by 164
Vuppalanchi, R., Liangpunsakul, S., & Chalasani, N. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01019.x · Cited by 160
Sharma, S. K., Singla, R., Sarda, P., Mohan, A., Makharia, G. K., Jayaswal, A., Sreenivas, V., & Singh, S. (2010) · Clinical Infectious Diseases · doi:10.1086/650576 · Cited by 159
Incidence of drug-induced liver injury in medical inpatients
Meier, Y., Cavallaro, M., Roos, M., Pauli-Magnus, C., Folkers, G., Meier, P. J., & Fattinger, K. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0888-z · Cited by 158
GARCÍA‐CORTÉS, M., LUCENA, M. I., PACHKORIA, K., BORRAZ, Y., HIDALGO, R., ANDRADE, R. J., & ON BEHALF OF THE SPANISH GROUP FOR THE STUDY OF DRUG‐INDUCED LIVER DISEASE (GRUPO DE ESTUDIO PARA LAS HEPATOPATÍAS ASOCIADAS A MEDICAMENTOS, G. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03655.x · Cited by 143
Self-citationDefinition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Medina-Caliz, I., Robles-Diaz, M., Garcia-Muñoz, B., Stephens, C., Ortega-Alonso, A., Garcia-Cortes, M., González-Jimenez, A., Sanabria-Cabrera, J. A., Moreno, I., Fernandez, M. C., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.003 · Cited by 140
Self-citationSundaram, V., & Björnsson, E. S. (2017) · Hepatology Communications · doi:10.1002/hep4.1088 · Cited by 138
Important Elements for the Diagnosis of Drug-Induced Liver Injury
Agarwal, V. K., McHutchison, J. G., & Hoofnagle, J. H. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.02.008 · Cited by 138
A missense variant in PTPN22 is a risk factor for drug-induced liver injury
Cirulli, E. T., Nicoletti, P., Abramson, K., Andrade, R. J., Bjornsson, E. S., Chalasani, N., Fontana, R. J., Hallberg, P., Li, Y. J., Lucena, M. I., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.034 · Cited by 137
Self-citationDrug-induced liver injury network (DILIN)
Hoofnagle, J. H. (2004) · Hepatology · doi:10.1002/hep.1840400403 · Cited by 134
The Spectrum of Hepatotoxicity
Zimmerman, H. J. (1968) · Perspectives in biology and medicine · doi:10.1353/pbm.1968.0004 · Cited by 134
Aithal, G. P., Rawlins, M. D., & Day, C. P. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80127-0 · Cited by 132
The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice
Björnsson, E., & Davidsdottir, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.021 · Cited by 131
Kenna, J. G., Taskar, K. S., Battista, C., Bourdet, D. L., Brouwer, K. L. R., Brouwer, K. R., Dai, D., Funk, C., Hafey, M. J., Lai, Y., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1222 · Cited by 130
Drug-Induced Liver Injury with Autoimmune Features
Foureau, D., Jacobs, C., Ahrens, W., Russo, M., Bonkovsky, H. L., & deLemos, A. S. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1375959 · Cited by 129
Hillman, L., Gottfried, M., Whitsett, M. P., Rakela, J. L., Schilsky, M. L., Lee, W. M., & Ganger, D. R. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.114 · Cited by 129
Dara, L., Liu, Z., & Kaplowitz, N. (2016) · Liver International · doi:10.1111/liv.12988 · Cited by 127
Models of Drug Induced Liver Injury (DILI)—Current Issues and Future Perspectives
Kuna, L., Bozic, I., Kizivat, T., Bojanic, K., Mrso, M., Kralj, E., Smolic, R., Wu, G. Y., & Smolic, M. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180523095355 · Cited by 127
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs
Urban, T. J., Shen, Y., Stolz, A., Chalasani, N., Fontana, R. J., Rochon, J., Ge, D., Shianna, K. V., Daly, A. K., Lucena, M. I., et al. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283589a76 · Cited by 125
Self-citationGoldberg, D. S., Forde, K. A., Carbonari, D. M., Lewis, J. D., Leidl, K. B. F., Reddy, K. R., Haynes, K., Roy, J. A., Sha, D., Marks, A. R., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.050 · Cited by 125
The management of anti-tuberculosis drug-induced hepatotoxicity.
Tahaoğlu, K., Ataç, G., Sevim, T., Tärün, T., Yazıcıoğlu, Ö. M., Horzum, G., Gemci, I., Ongel, A., Kapaklı, N., & Aksoy, E. (2001) · PubMed · Cited by 123
Death and liver transplantation within 2 years of onset of drug‐induced liver injury
Hayashi, P. H., Rockey, D. C., Fontana, R. J., Tillmann, H. L., Kaplowitz, N., Barnhart, H. X., Gu, J., Chalasani, N. P., Reddy, K. R., Sherker, A. H., et al. (2017) · Hepatology · doi:10.1002/hep.29283 · Cited by 123
Causality Assessment Versus Guilt–By–Association in Drug Hepatotoxicity
Kaplowitz, N. (2001) · Hepatology · doi:10.1053/jhep.2001.21083 · Cited by 122
Lauschke, V. M., Vorrink, S. U., Moro, S. M. L., Rezayee, F., Nordling, Å., Hendriks, D. F. G., Bell, C. C., Sison‐Young, R., Park, B. K., Goldring, C. E., et al. (2016) · Hepatology · doi:10.1002/hep.28780 · Cited by 121
For the Drug Induced Liver Injury Network (DILIN), Vega, M., Verma, M., Beswick, D., Bey, S., Hossack, J., Merriman, N., Shah, A., & Navarro, V. (2017) · Drug Safety · doi:10.1007/s40264-017-0547-9 · Cited by 120
Stine, J. G., & Lewis, J. H. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1127756 · Cited by 104
Fontana, R. J., Hayashi, P. H., Barnhart, H., Kleiner, D. E., Reddy, R. K., Chalasani, N., Lee, W. M., Stolz, A., Phillips, T., Serrano, J., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.283 · Cited by 101
Drug-induced liver injury in obesity
Fromenty, B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.018 · Cited by 101
Chai, C., Rivkin, M., Berkovits, L., Simerzin, A., Zorde-Khvalevsky, E., Rosenberg, N., Klein, S., Yaish, D., Durst, R., Shpitzen, S., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.013 · Cited by 100
Kim, S., Saide, K., Farrell, J., Faulkner, L., Tailor, A., Ogese, M. O., Daly, A. K., Pirmohamed, M., Park, B. K., & Naisbitt, D. J. (2015) · Hepatology · doi:10.1002/hep.27912 · Cited by 98
Jennings, J. J., Mandaliya, R. H., Nakshabandi, A., & Lewis, J. H. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1574744 · Cited by 98
Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors
Miller, E., Abu‐Sbeih, H., Styskel, B. A., Nogueras‐González, G. M., Blechacz, B. R. A., Naing, A., & Chalasani, N. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000398 · Cited by 98
Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: a single center report of 8 cases
Rodrigues, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i24.7584 · Cited by 97
Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice
Selwyn, F. P., Cheng, S. L., Bammler, T. K., Prasad, B., Vrana, M., Klaassen, C. D., & Cui, J. Y. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv110 · Cited by 96
Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury
Wree, A., Dechêne, A., Herzer, K., Hilgard, P., Syn, W.-K., Gerken, G., & Canbay, A. (2011) · Digestion · doi:10.1159/000322298 · Cited by 93
Monitoring and management of antituberculosis drug induced hepatotoxicity
Agal, S., Baijal, R., PRAMANIK, S., PATEL, N., Gupte, P., Kamani, P. M., & Amarapurkar, D. N. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04048.x · Cited by 89
Devarbhavi, H. C., Karanth, D., Prasanna, K. S., Adarsh, C. K., & Patil, M. (2011) · Hepatology · doi:10.1002/hep.24527 · Cited by 88
Discovery of Keap1−Nrf2 small−molecule inhibitors from phytochemicals based on molecular docking
Li, M., Huang, W., Jie, F., Wang, M., Zhong, Y., Chen, Q., & Lu, B. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110758 · Cited by 87
Perdices, E. V., Medina‐Cáliz, I., Hernando, S., Ortega, A., Martín-Ocaña, F., Navarro, J. M., Peláez, G. I. C., Castiella, A., Hallal, H., Romero‐Gómez, M., et al. (2014) · PubMed · Cited by 86
Self-citationLomtadze, N., Kupreishvili, L., Salakaia, A., Vashakidze, S. A., Sharvadze, L., Kempker, R. R., Magee, M. J., del Río, C., & Blumberg, H. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083892 · Cited by 84
Björnsson, E. S., Bergmann, O., Jonasson, J. G., Grondal, G., Gudbjornsson, B., & Olafsson, S. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.05.027 · Cited by 84
Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications
Kaliyaperumal, K., Grove, J. I., Delahay, R. M., Griffiths, W. J., Duckworth, A., & Aithal, G. P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.013 · Cited by 84
Causality assessment in drug-induced hepatotoxicity
Andrade, R. J., Camargo, R., Lucena, M. I., & González‐Grande, R. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.4.329 · Cited by 82
Self-citationRobles‐Díaz, M., García‐Cortés, M., Medina‐Cáliz, I., Gonzalez-Jimenez, A., González‐Grande, R., Navarro, J. M., Castiella, A., Zapata, E. M., Romero‐Gómez, M., Blanco, S., et al. (2015) · Liver International · doi:10.1111/liv.12834 · Cited by 81
Self-citationBagheri, H., Michel, F., Lapeyre‐Mestre, M., Lagier, E., Cambus, J., Valdiguié, P. M., & Montastruc, J. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00282.x · Cited by 77
Re, V. L., Haynes, K., Forde, K. A., Goldberg, D. S., Lewis, J. D., Carbonari, D. M., Leidl, K. B. F., Reddy, K. R., Nezamzadeh, M. S., Roy, J. A., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.06.020 · Cited by 76
A generic operational strategy to qualify translational safety biomarkers
Matheis, K. A., Laurie, D., Andriamandroso, C., Arber, N., Badimón, L., Benain, X., Bendjama, K., Clavier, I., Colman, P., Firat, H., et al. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.04.011 · Cited by 73
Drug rechallenge following drug-induced liver injury
Hunt, C. M., Papay, J. I., Stanulovic, V., & Regev, A. (2017) · Hepatology · doi:10.1002/hep.29152 · Cited by 72
Rodríguez, L. A. G., Ruigómez, A., & Jick, H. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03747.x · Cited by 71
Consensus meetings on: Causality assessment of drug-induced liver injury
Danan, G. (1988) · Journal of Hepatology · doi:10.1016/s0168-8278(88)80517-8 · Cited by 70
Devarbhavi, H. C., Patil, M., Reddy, V. V., Singh, R., Joseph, T., & Ganga, D. (2017) · Liver International · doi:10.1111/liv.13662 · Cited by 69
Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI
Chan, R., & Benet, L. Z. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx284 · Cited by 69
Takikawa, H. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00232-8 · Cited by 68
Devarbhavi, H. C., Raj, S., Venu, A., Rangegowda, V. T., Veeranna, G. P., Singh, R., Reddy, V., & Patil, M. (2015) · Hepatology · doi:10.1002/hep.28270 · Cited by 67
Wang, Y., Wang, Z., Gao, M., Zhong, H., Chen, C., Yao, Y., Zhang, Z., Zhang, X., Li, F., Zhang, J., et al. (2019) · Liver International · doi:10.1111/liv.14204 · Cited by 66
Dash, A., Figler, R. A., Sanyal, A. J., & Wamhoff, B. R. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1246534 · Cited by 65
Hunt, C. M., Yuen, N., Stirnadel-Farrant, H. A., & Suzuki, A. (2014) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2014.09.007 · Cited by 64
Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis
Czaja, A. J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9257 · Cited by 64
Diagnostic and prognostic assessment of suspected drug‐induced liver injury in clinical practice
Andrade, R. J., & Robles‐Díaz, M. (2019) · Liver International · doi:10.1111/liv.14271 · Cited by 64
Self-citationCurrent Challenges and Controversies in Drug-Induced Liver Injury
Corsini, A., Ganey, P. E., Ju, C., Kaplowitz, N., Pessayre, D., Roth, R. A., Watkins, P. B., Albassam, M., Liu, B., Stancic, S., et al. (2012) · Drug Safety · doi:10.1007/bf03261997 · Cited by 63
Long‐term follow‐up of patients with mild to moderate drug‐induced liver injury
Bjornsson, E. S., Kalaitzakis, E., KLINTEBERG, V. A., ALEM, N., & Olsson, R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03355.x · Cited by 62
Rathi, C., Pipaliya, N., Patel, R., Ingle, M., Phadke, A., & Sawant, P. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0009.8600 · Cited by 61
Secondary sclerosing cholangitis in patients with drug-induced liver injury
Gudnason, H. O., Björnsson, H. K., Garðarsdóttir, M., Thorisson, H. M., Ólafsson, S., Bergmann, O. M., & Bjornsson, E. S. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.03.002 · Cited by 61
Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States
Hayashi, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020201 · Cited by 60
Post-halothane Jaundice in Relation to Previous Administration of Halothane
Mushin, W. W., Rosen, M., & Jones, E. V. (1971) · BMJ · doi:10.1136/bmj.3.5765.18 · Cited by 59
Gutthann, S. P., & Garcia Rodeíguez, L. A. (1993) · Epidemiology · doi:10.1097/00001648-199311000-00004 · Cited by 58
Toda, T., Ohi, K., Kudo, T., Yoshida, T., Ikarashi, N., Ito, K., & Sugiyama, K. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.201 · Cited by 58
Severe Jaundice in Sweden in the New Millennium: Causes, Investigations, Treatment and Prognosis
Björnsson, E., Ismael, S., Nejdet, S., & Kilander, A. F. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000492 · Cited by 57
Powles, T. B., Sergio Bracarda, A., Chen, M., Norry, E., Compton, N., Heise, M. A., Hutson, T. E., Harter, P., Carpenter, C. L., Pandite, L. N., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.03.019 · Cited by 56
A new method for assessing drug causation provided agreement with experts' judgment
Arimone, Y., Bégaud, B., Miremont-Salamé, G., Fourrier-Réglat, A., Molimard, M., Moore, N., & Haramburu, F. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.08.012 · Cited by 54
Case Report: Terbinafine-Induced Prolonged Cholestasis with Reduction of Interlobular Bile Ducts
Mallat, A., Zafrani, É. S., Métreau, J., & Dhumeaux, D. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018870828038 · Cited by 53
Regulation of autoimmune and anti‐tumour T‐cell responses by PTPN 22
Brownlie, R. J., Zamoyska, R., & Salmond, R. J. (2018) · Immunology · doi:10.1111/imm.12919 · Cited by 53
Rechallenge in drug-induced liver injury: the attractive hazard
Andrade, R. J., Robles, M., & Lucena, M. I. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903397378 · Cited by 52
Self-citationGhabril, M., Gu, J., Yoder, L., Corbito, L., Ringel, A., Beyer, C. D., Vuppalanchi, R., Barnhart, H., Hayashi, P. H., & Chalasani, N. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.07.006 · Cited by 52
Causality Assessment for Suspected DILI During Clinical Phases of Drug Development
Regev, A., Seeff, L. B., Merz, M., Ormarsdottir, S., Aithal, G. P., Gallivan, J., & Watkins, P. B. (2014) · Drug Safety · doi:10.1007/s40264-014-0185-4 · Cited by 51
Benesic, A., Leitl, A., & Gerbes, A. L. (2016) · Gut · doi:10.1136/gutjnl-2015-309528 · Cited by 48
Sun, Q., Zhang, Q., Gu, J., Sun, W., Wang, P., Bai, C., Xiao, H., & Sha, W. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3988 · Cited by 48
Molokhia, M., & McKeigue, P. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.4.633 · Cited by 47
Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury
George, N., Chen, M., Yuen, N., Hunt, C. M., & Suzuki, A. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.01.018 · Cited by 46
Katsinelos, P., Vasiliadis, T., Xiarchos, P., Patakiouta, F., Christodoulou, K., Pilpilidis, I., & Eugenidis, N. (2000) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200012030-00017 · Cited by 44
WATANABE, M. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.08.005 · Cited by 44
Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures
Rodrigues, R. M., Kollipara, L., Chaudhari, U., Sachinidis, A., Zahedi, R. P., Sickmann, A., Kopp‐Schneider, A., Jiang, X., Keun, H. C., Hengstler, J. G., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2214-z · Cited by 44
Histopathological challenges in suspected drug‐induced liver injury
Kleiner, D. E. (2018) · Liver International · doi:10.1111/liv.13584 · Cited by 42
Holman, N. S., Church, R. J., Nautiyal, M., Rose, K., Thacker, S. E., Otieno, M. A., Wolf, K., LeCluyse, E. L., Watkins, P. B., & Mosedale, M. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz112 · Cited by 42
Devarbhavi, H. C., & Raj, S. (2018) · Liver International · doi:10.1111/liv.14004 · Cited by 39
Whritenour, J., Ko, M., Zong, Q., Wang, J., Tartaro, K., Schneider, P., Olson, E., Van Volkenburg, M., Serrano, J., Hayashi, P., et al. (2017) · Journal of Immunotoxicology · doi:10.1080/1547691x.2016.1254305 · Cited by 37
Carrascosa, M. F., Salcines-Caviedes, J. R., Lucena, M. I., & Andrade, R. J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.019 · Cited by 34
Self-citationGenetic Predisposition to Drug-Induced Liver Injury
Stephens, C. M., & Andrade, R. J. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.08.003 · Cited by 34
Self-citationCheetham, T. C., Lee, J., Hunt, C. M., Niu, F., Reisinger, S. J., Murray, R., Powell, G., & Papay, J. I. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3531 · Cited by 33
Viral hepatitis prevalence in patients with active and latent tuberculosis
Nooredinvand, H. A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8920 · Cited by 31
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical Practice
Bessone, F., Robles‐Díaz, M., Hernández, N., Medina‐Cáliz, I., Lucena, M. I., & Andrade, R. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1685519 · Cited by 31
Self-citationJeong, R.-B., Lee, Y., Sohn, C.-H., Jeon, J. Y., Ahn, S., & Lim, K. S. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.958094 · Cited by 30
Roytman, M. M., Poerzgen, P., & Navarro, V. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1097 · Cited by 30
Xiao, X., Tang, J., Mao, Y., Li, X., Wang, J., Liu, C., Sun, K., Ye, Y., Zou, Z., Peng, C., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.12.003 · Cited by 30
Paniagua, A. C., Amariles, P., Angulo, N., & Restrepo-Garay, M. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2018.11.008 · Cited by 29
Serum Glutamate Dehydrogenase—Biomarker for Liver Cell Death or Mitochondrial Dysfunction?
Jaeschke, H., & McGill, M. R. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft087 · Cited by 28
Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury
Ogimura, E., Nakagawa, T., Deguchi, J., Sekine, S., Ito, K., & Bando, K. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx091 · Cited by 28
Ursodeoxycholic acid for the treatment of fluchoxacillin-associated cholestasis
Piotrowicz, A., Polkey, M. I., & Wilkinson, M. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80272-x · Cited by 26
Lang, S., Ortmann, J., Rostig, S., & Schiffl, H. (2019) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_159_18 · Cited by 23
Devarbhavi, H. C., Raj, S., Joseph, T., Singh, R., & Patil, M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.05.031 · Cited by 21
Variation in the gut microbial community is associated with the progression of liver regeneration
Bao, Q., Yu, L., Chen, D.-Y., & Li, L.-J. (2020) · Hepatology Research · doi:10.1111/hepr.13424 · Cited by 19
Amoxicillin/clavulanic acid-induced cholestatic liver injury after pediatric liver transplantation
Pawłowska, J. (2012) · Annals of Transplantation · doi:10.12659/aot.882646 · Cited by 18
Sanabria‐Cabrera, J., Medina‐Cáliz, I., Stankevičiūtė, S., Rodríguez-Nicolás, A., Almarza-Torres, M., Lucena, M. I., & Andrade, R. J. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191107161912 · Cited by 17
Self-citationScalfaro, E., Streefkerk, H. J., Merz, M., Meier, C., & Lewis, D. (2017) · Drug Safety · doi:10.1007/s40264-017-0541-2 · Cited by 16
Castañer, A. F., García‐Cortés, M., Lucena, M. I., Borraz, Y., Peláez, G. I. C., Costa, J., Anzola, S., Salmerón, J. F. M., Ávila, S. P. G., Durán, J. A., et al. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008000500006 · Cited by 14
Self-citationDrug-Induced Liver Injury Resources and Reporting for the Clinician
Isaacson, M., & Babich, M. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.09.010 · Cited by 12
Caines, A. N., & Moonka, D. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.09.001 · Cited by 11
Autoimmune hepatitis and anti-tumor necrosis factor alphatherapy: A single center report of 8 cases
susana, Rodrigues, Lopes, Fernando, Magro, lder, Cardoso, Ana, A., Fragaki, M., Horta, et al. (2015) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 11
(2020) · doi:10.56759/ojsg8296 · Cited by 11
Bonkovsky, H. L., Severson, T. J., Nicoletti, P., Barnhart, H. X., Serrano, J., Chalasani, N., Fontana, R. J., Watkins, P. B., Navarro, V., Stolz, A., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1382 · Cited by 9
Pro-Euro-Dili Registry: A Collaborative Effort to Enhance the Understanding of Dili
Slim, M., Stephens, C., Robles‐Díaz, M., Medina‐Cáliz, I., Grove, J. I., Ortega‐Alonso, A., Lucena, M. I., Aithal, G. P., & Andrade, R. J. (2016) · Journal of Hepatology · doi:10.1016/s0168-8278(16)00370-6 · Cited by 8
Self-citationFontana, R. J., & Bari, K. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch17 · Cited by 6
Nefazodone in community use: the results of prescription-event monitoring
Mackay, F. J., Pearce, G. L., Freemantle, S. N., & Mann, R. D. (1999) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(sici)1099-1557(199907)8:4<275::aid-pds427>3.0.co;2-d · Cited by 5
Cited by
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Drug induced liver injury – a 2023 update
Allison, R., Guraka, A., Shawa, I. T., Tripathi, G., Moritz, W., & Kermanizadeh, A. (2023) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2023.2261848 · Cited by 167
“Characteristics vary from being asymptomatic with only slightly elevated alanine aminotransferase (ALT) levels to jaundice, encephalopathy, and acute liver failure (Danan and Benichou 1993; Garcia-Cortes et al. 2020).”
BackgroundInfluentialIncidence and risk factors of drug‐induced liver injury
Li, X., Tang, J., & Mao, Y. (2022) · Liver International · doi:10.1111/liv.15262 · Cited by 158
Herbal hepatotoxicity: Clinical characteristics and listing compilation
Frenzel, C., & Teschke, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050588 · Cited by 122
Metadata
- Authors
- Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M. I., & Andrade, R. J.
- Venue
- Archives of Toxicology
- Published
- 2020-08-27
- Volume
- 94
- Issue
- 10
- Pages
- 3381-3407
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W3080297463
- Cited by
- 286
- References
- 194
- FWCI
- 24.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.